News That Matters

Tag: Creative Medical Technology Holdings

Creative Medical Technology Announces Positive Top-Line Results for OvaStem® Pilot Study
Technology

Creative Medical Technology Announces Positive Top-Line Results for OvaStem® Pilot Study

Three-Year Follow Up Results Confirm Significant Efficacy and No Serious Adverse Effects in Patients receiving OvaStem® Procedure for Treating Primary Ovarian Insufficiency PHOENIX, July 28, 2022 /PRNewswire/ -- Creative Medical Technology Holdings, Inc. ("Creative Medical Technology" or the "Company") (NASDAQ: CELZ), a leading commercial stage biotechnology company focused on a regenerative approach to immunotherapy, urology, neurology, and orthopedics, today announced positive three-year follow up data for the Company's OvaStem® pilot study.  The data shows significant efficacy of the OvaStem® procedure for the treatment of medical refractory Primary Ovarian Insufficiency (POI) without any serious adverse effects and the successful birth of healthy babies. OvaStem® is a patented outp...